metoprolol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pridopidine is an oral drug in clinical development for treatment of patients with Huntington's disease." | 1.46 | Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease. ( Hallak, H; Muglia, P; Pastino, G; Rabinovich-Guilatt, L; Spiegelstein, O; Steiner, L, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rabinovich-Guilatt, L | 1 |
| Steiner, L | 1 |
| Hallak, H | 1 |
| Pastino, G | 1 |
| Muglia, P | 1 |
| Spiegelstein, O | 1 |
| Gupta, S | 1 |
| Misra, G | 1 |
| Pant, MC | 1 |
| Seth, PK | 1 |
2 other studies available for metoprolol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.
Topics: Area Under Curve; Cells, Cultured; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP | 2017 |
Prediction of a new surface binding pocket and evaluation of inhibitors against huntingtin interacting protein 14: an insight using docking studies.
Topics: Acyltransferases; Adaptor Proteins, Signal Transducing; Binding Sites; Enzyme Inhibitors; Fluorodeox | 2011 |